ITGAM and pancreatic neuroendocrine tumor: In response to the hypoxic environment and to reinitiate angiogenesis, sorafenib-resistant pancreatic neuroendocrine tumors in the Rip1Tag2 model exhibit increased infiltration of pro-tumor Gr1+ monocytes and neutrophils, along with PI3Kγ-enriched CD11b+ immune cells.